DOI:
10.1055/s-00000030
Der Klinikarzt
LinksClose Window
References
Dulai PS, Singh S, Jiang X. et al
The real-world effectiveness and safety of vedolizumab for moderate-severe crohn’s disease: results from the US victory consortium.
Am J Gastroenterol 2016;
111: 1147-1155
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.